Range Low Price High Price Comment
30 days $0.415 $0.675 Tuesday, 30th Apr 2024 EVOK stock ended at $0.450. This is 2.27% more than the trading day before Monday, 29th Apr 2024. During the day the stock fluctuated 12.00% from a day low at $0.415 to a day high of $0.465.
90 days $0.415 $0.760
52 weeks $0.415 $2.39

Historical Evoke Pharma prices

Date Open High Low Close Volume
Feb 02, 2016 $3.21 $3.32 $3.07 $3.11 6 600
Feb 01, 2016 $3.25 $3.37 $3.08 $3.24 28 500
Jan 29, 2016 $3.09 $3.36 $3.09 $3.16 34 700
Jan 28, 2016 $3.21 $3.21 $3.03 $3.07 8 600
Jan 27, 2016 $3.37 $3.37 $3.10 $3.23 41 500
Jan 26, 2016 $3.40 $3.40 $3.27 $3.34 27 100
Jan 25, 2016 $3.38 $3.41 $3.17 $3.26 13 600
Jan 22, 2016 $3.15 $3.35 $3.00 $3.23 66 100
Jan 21, 2016 $2.84 $3.14 $2.81 $3.09 41 700
Jan 20, 2016 $2.60 $2.81 $2.37 $2.78 72 900
Jan 19, 2016 $2.73 $2.75 $2.47 $2.65 45 900
Jan 15, 2016 $2.69 $2.77 $2.62 $2.69 10 000
Jan 14, 2016 $2.66 $2.80 $2.55 $2.73 56 700
Jan 13, 2016 $2.97 $2.97 $2.47 $2.59 85 600
Jan 12, 2016 $2.78 $2.92 $2.64 $2.72 48 600
Jan 11, 2016 $2.96 $3.03 $2.75 $2.78 100 400
Jan 08, 2016 $3.05 $3.09 $2.93 $2.96 43 000
Jan 07, 2016 $3.16 $3.38 $3.00 $3.04 161 200
Jan 06, 2016 $3.20 $3.24 $3.10 $3.15 11 500
Jan 05, 2016 $3.31 $3.34 $3.16 $3.25 28 500
Click to get the best stock tips daily for free!

About Evoke Pharma

Evoke Pharma Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine ... EVOK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT